Active, not recruitingPhase 2NCT05703074

Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid

Studying Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Akershus
Principal Investigator
Torbjørn Omland, PhD
Akershus University Hospital/University of Oslo
Intervention
Nicotinamide Riboside (NR)(dietary_supplement)
Enrollment
310 target
Eligibility
18-70 years · All sexes
Timeline
20232025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05703074 on ClinicalTrials.gov

Other trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Additional recruiting or active studies for the same condition.

See all trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

← Back to all trials